References
Saleem S, Aslam HM, Anwar M, Anwar S, Saleem M, Saleem A, Rehmanie MA (2013) Fahr’s syndrome: literature review of current evidence. Orphanet J Rare Dis 8:156
Westenberger A, Klein C (2014) The genetics of primary familial brain calcifications. Curr Neurol Neurosci Rep 14:490
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G et al (2018) Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol 14:476–500
Mantovani G (2011) Clinical review: pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 96:3020–3030
Song CY, Zhao ZX, Li W, Sun CC, Liu YM (2017) Pseudohypoparathyroidism with basal ganglia calcification: a case report of rare cause of reversible Parkinsonism. Medicine 96:e6312
Funding
This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
David, K., Stinkens, K. & Decallonne, B. Pseudohypoparathyroidism: a missed window of treatment opportunity?. Acta Neurol Belg 121, 259–260 (2021). https://doi.org/10.1007/s13760-019-01268-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-019-01268-3